SCHEMBL28526013

SCHEMBL28526013

C=C(C)C(=O)Nc1ccc(OC(F)(F)F)c(Br)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.58
POLB P06746 2/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
EPHX2 P34913 2/20 0.49
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
RXFP1 Q9HBX9 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
KCNK3 O14649 3/20 0.41
KCNK9 Q9NPC2 3/20 0.41
RECQL P46063 2/20 0.41
BLM P54132 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GSTO1 P78417 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
BRD4 O60885 1/20 0.39
PNLIP P16233 1/20 0.38
BAZ1A Q9NRL2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4855842 0.86 ALDH1A1 (0.55) TDP1L3MBTL1EPHX2CYP1A2CYP2C9
SCHEMBL6160971 0.81 EPHX2 (0.55) POLBEPHX2CYP1A2CYP2C9CYP2C19
SCHEMBL5804037 0.81 CYP1A2 (0.59) L3MBTL1EPHX2CYP1A2CYP2C9CYP2C19
SCHEMBL5914903 0.80 DHODH (0.57) TDP1POLBL3MBTL1EPHX2CYP1A2
SCHEMBL5914904 0.80 DHODH (0.57) TDP1POLBL3MBTL1EPHX2CYP1A2
SCHEMBL2347463 0.78 EPHX2 (0.49) EPHX2CYP1A2CYP2C9CYP2C19RXFP1
SCHEMBL28526011 0.77 EPHX2 (0.48) POLBEPHX2CYP1A2CYP2C9CYP2C19
SCHEMBL7778855 0.77 EPHX2 (0.65) TDP1POLBL3MBTL1EPHX2RXFP1
SCHEMBL201743 0.76 EPHX1 (0.63) TDP1POLBL3MBTL1RXFP1
SCHEMBL8155266 0.75 EPHX2 (0.41) L3MBTL1EPHX2CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112472699-A Combination methods for improving the therapeutic benefit of bisantrene and derivatives 种族肿瘤学公司 2021-03-12 CN disclosed